| |
 |
Providing Contract R&D Services and Patent Protected Expression Systems
for Your Recombinant Protein.
New Technologies
|
|
 news |
25.02.2008 ARTES and m2p-labs join forces and offer an exclusive technology combination
ARTES Biotechnology GmbH (Langenfeld) and m2p-labs GmbH (Aachen) announced today the start of a long-term collaboration in clone screening and media optimisation.
The two companies combine their proprietary technologies and know-how in yeast expression and high throughput fermentation. In this exclusive collaboration the two companies offer strain selection, physiological characterization and media optimization with the two yeast systems Hansenula polymorpha and Arxula adeninivorans. The combination of this high-productive expression systems and the powerful BioLector screening tool provide much more physiological data at a high throughput level in screening and early bioprocess development.
Both companies are convinced that their clients will profit from this new technology offer by reduced time lines in strain and process development, the availability of new carbon sources and more productive clones and culture conditions.
|
|
|
|
